Na-Yun Lyu, Guo-Guang Xie, Zhi-Wen Hu, Tian-Jie Lyu, Rui Qin, Lu Chen, Yun Wang
{"title":"CDK5介导的CDYL活性依赖性磷酸化调节小鼠的恐惧记忆。","authors":"Na-Yun Lyu, Guo-Guang Xie, Zhi-Wen Hu, Tian-Jie Lyu, Rui Qin, Lu Chen, Yun Wang","doi":"10.1038/s41398-025-03568-0","DOIUrl":null,"url":null,"abstract":"<p><p>Fear memory is crucial for animals to effectively respond to dynamic environments and survive dangerous stimuli. However, aberrant fear memory contributes to various psychiatric disorders, such as post-traumatic stress disorder (PTSD). Despite its importance, the precise molecular mechanisms underlying fear memory remain insufficiently understood. In this study, we highlight the pivotal role of the epigenetic factor chromodomain Y-like protein (CDYL) in the regulation of fear memory. We discovered that ablation of CDYL in CaMKIIα<sup>+</sup> excitatory neurons in the forebrain or hippocampus leads to increased fear memory in mice. CDYL is phosphorylated by cyclin-dependent kinase 5 (CDK5) at Ser147, which facilitates tripartite motif containing 32 (TRIM32)-mediated ubiquitination and degradation of CDYL in response to neural activity. Additionally, we developed an interfering peptide that specifically targets the phosphorylation of CDYL at Ser147, resulting in a decrease in contextual fear memory in mice. Collectively, our findings underscore the essential role of CDYL in fear memory and illustrate the modulatory function of CDK5 and TRIM32 on CDYL, positioning CDYL as a promising target for the modulation of fear memory.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"334"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398608/pdf/","citationCount":"0","resultStr":"{\"title\":\"Activity-dependent phosphorylation of CDYL by CDK5 regulates fear memory in mice.\",\"authors\":\"Na-Yun Lyu, Guo-Guang Xie, Zhi-Wen Hu, Tian-Jie Lyu, Rui Qin, Lu Chen, Yun Wang\",\"doi\":\"10.1038/s41398-025-03568-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Fear memory is crucial for animals to effectively respond to dynamic environments and survive dangerous stimuli. However, aberrant fear memory contributes to various psychiatric disorders, such as post-traumatic stress disorder (PTSD). Despite its importance, the precise molecular mechanisms underlying fear memory remain insufficiently understood. In this study, we highlight the pivotal role of the epigenetic factor chromodomain Y-like protein (CDYL) in the regulation of fear memory. We discovered that ablation of CDYL in CaMKIIα<sup>+</sup> excitatory neurons in the forebrain or hippocampus leads to increased fear memory in mice. CDYL is phosphorylated by cyclin-dependent kinase 5 (CDK5) at Ser147, which facilitates tripartite motif containing 32 (TRIM32)-mediated ubiquitination and degradation of CDYL in response to neural activity. Additionally, we developed an interfering peptide that specifically targets the phosphorylation of CDYL at Ser147, resulting in a decrease in contextual fear memory in mice. Collectively, our findings underscore the essential role of CDYL in fear memory and illustrate the modulatory function of CDK5 and TRIM32 on CDYL, positioning CDYL as a promising target for the modulation of fear memory.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"15 1\",\"pages\":\"334\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2025-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398608/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-025-03568-0\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03568-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Activity-dependent phosphorylation of CDYL by CDK5 regulates fear memory in mice.
Fear memory is crucial for animals to effectively respond to dynamic environments and survive dangerous stimuli. However, aberrant fear memory contributes to various psychiatric disorders, such as post-traumatic stress disorder (PTSD). Despite its importance, the precise molecular mechanisms underlying fear memory remain insufficiently understood. In this study, we highlight the pivotal role of the epigenetic factor chromodomain Y-like protein (CDYL) in the regulation of fear memory. We discovered that ablation of CDYL in CaMKIIα+ excitatory neurons in the forebrain or hippocampus leads to increased fear memory in mice. CDYL is phosphorylated by cyclin-dependent kinase 5 (CDK5) at Ser147, which facilitates tripartite motif containing 32 (TRIM32)-mediated ubiquitination and degradation of CDYL in response to neural activity. Additionally, we developed an interfering peptide that specifically targets the phosphorylation of CDYL at Ser147, resulting in a decrease in contextual fear memory in mice. Collectively, our findings underscore the essential role of CDYL in fear memory and illustrate the modulatory function of CDK5 and TRIM32 on CDYL, positioning CDYL as a promising target for the modulation of fear memory.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.